# MedTracker Monetization Strategy (The "UK Moat")

## 1. Core Philosophy: "Confidence as a Service"
MedTracker is open-source to maximize trust and adoption, but it is **"Regulated-by-Design."** The business model focuses on selling the **Permission to Operate** and **Forensic-Grade Security** required by high-stakes clinical environments.

---

## 2. Monetization Pillars

### Pillar A: "Dedicated" Managed Service (B2B/Enterprise)
Following the **"GitLab Dedicated"** model, provide fully isolated instances for NHS Trusts, Care Homes, and Private Clinics.
*   **The Value:** Data Isolation and Residency. Each customer gets a dedicated K8s namespace and isolated PostgreSQL database.
*   **Target:** Organizations that refuse multi-tenant/shared-DB SaaS for security reasons.
*   **Monetization:** High-margin monthly subscription ($499+/mo) + Setup fee.

### Pillar B: Compliance-as-a-Service (UK Moat)
Leverage the high regulatory hurdle for UK health tech.
*   **Compliance Kit:** Sell a proprietary "Evidence Pack" for $2,500+ (or included in Enterprise).
    *   Pre-filled **DCB0129 Clinical Safety Case** and Hazard Logs.
    *   **DPIA (Data Protection Impact Assessment)** templates.
    *   **DTAC (Digital Technology Assessment Criteria)** mapping for NHS procurement.
*   **CSO-as-a-Service:** Provide outsourced **Clinical Safety Officer (CSO)** consultation to help customers sign off on their **DCB0160** obligations.

### Pillar C: Premium Data Connectors & Automation
Monetize high-quality clinical data and labor-saving automations.
*   **Auto-Ordering:** Integrate with Pharmacy APIs (e.g., Phlo, Pharmacy2U).
    *   **Model:** Commission-per-order or referral fees from the pharmacy.
    *   **B2B Value:** Massive labor saving for care homes by automating manual reordering.
*   **Clinical Intelligence Add-ons:** 
    *   Closed-source connectors for **DrugBank**, **BNF**, or **OpenFDA**.
    *   **Features:** Real-time Drug-Drug Interaction (DDI) checks and allergy alerts.

### Pillar D: Hardened Security Modules
Features required for "High-Assurance" clinical use.
*   **Forensic Audit Logs:** Tamper-evident log chaining, WORM (Write Once Read Many) storage support, and 10-year immutable retention.
*   **SSO/OIDC Integration:** Custom enterprise identity provider mapping.

---

## 3. Implementation Roadmap
1.  **[Core]** Multi-tenancy vs. Isolation strategy (Completed: `reorder_status` added to `Medicine`).
2.  **[Security]** Hardened Audit Log implementation (Issue #509).
3.  **[Infrastructure]** Develop Helm/Terraform for "Dedicated" deployment pattern.
4.  **[Content]** Build the "Compliance Starter Kit" (DCB0129/DPIA templates).
5.  **[Integration]** Prototype a generic `PharmacyConnector` interface.

---

## 4. References
*   [NHS DTAC](https://www.england.nhs.uk/digital-technology-assessment-criteria-dtac/)
*   [DCB0129 Standards](https://digital.nhs.uk/data-and-information/information-standards/dcb0129)
*   [UK GDPR Article 32](https://www.legislation.gov.uk/eur/2016/679/article/32)
